These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Coverage of diarrhoea-associated Escherichia coli isolates from different origins with two types of phage cocktails. Bourdin G; Navarro A; Sarker SA; Pittet AC; Qadri F; Sultana S; Cravioto A; Talukder KA; Reuteler G; Brüssow H Microb Biotechnol; 2014 Mar; 7(2):165-76. PubMed ID: 24528873 [TBL] [Abstract][Full Text] [Related]
11. In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli. Weiss M; Denou E; Bruttin A; Serra-Moreno R; Dillmann ML; Brüssow H Virology; 2009 Oct; 393(1):16-23. PubMed ID: 19699505 [TBL] [Abstract][Full Text] [Related]
12. From bench to bed and back again: phage therapy of childhood Escherichia coli diarrhea. Sarker SA; Brüssow H Ann N Y Acad Sci; 2016 May; 1372(1):42-52. PubMed ID: 27197768 [TBL] [Abstract][Full Text] [Related]
13. Genome analysis of phage JS98 defines a fourth major subgroup of T4-like phages in Escherichia coli. Zuber S; Ngom-Bru C; Barretto C; Bruttin A; Brüssow H; Denou E J Bacteriol; 2007 Nov; 189(22):8206-14. PubMed ID: 17693496 [TBL] [Abstract][Full Text] [Related]
14. Amplification and purification of T4-like escherichia coli phages for phage therapy: from laboratory to pilot scale. Bourdin G; Schmitt B; Marvin Guy L; Germond JE; Zuber S; Michot L; Reuteler G; Brüssow H Appl Environ Microbiol; 2014 Feb; 80(4):1469-76. PubMed ID: 24362424 [TBL] [Abstract][Full Text] [Related]
15. Genomics of staphylococcal Twort-like phages--potential therapeutics of the post-antibiotic era. Łobocka M; Hejnowicz MS; Dąbrowski K; Gozdek A; Kosakowski J; Witkowska M; Ulatowska MI; Weber-Dąbrowska B; Kwiatek M; Parasion S; Gawor J; Kosowska H; Głowacka A Adv Virus Res; 2012; 83():143-216. PubMed ID: 22748811 [TBL] [Abstract][Full Text] [Related]
16. IgA response of BALB/c mice to orally administered Salmonella typhimurium flagellin-displaying T2 bacteriophages. Synnott A; Ohshima K; Nakai Y; Tanji Y Biotechnol Prog; 2009; 25(2):552-8. PubMed ID: 19334277 [TBL] [Abstract][Full Text] [Related]
17. Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers. Vaughan D; Speed J; Medve R; Andrews JS Clin Ther; 2010 Jan; 32(1):146-60. PubMed ID: 20171420 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of phage treatment as a strategy to reduce Salmonella populations in growing swine. Callaway TR; Edrington TS; Brabban A; Kutter B; Karriker L; Stahl C; Wagstrom E; Anderson R; Poole TL; Genovese K; Krueger N; Harvey R; Nisbet DJ Foodborne Pathog Dis; 2011 Feb; 8(2):261-6. PubMed ID: 21034249 [TBL] [Abstract][Full Text] [Related]
19. Toward rational control of Escherichia coli O157:H7 by a phage cocktail. Tanji Y; Shimada T; Yoichi M; Miyanaga K; Hori K; Unno H Appl Microbiol Biotechnol; 2004 Apr; 64(2):270-4. PubMed ID: 13680205 [TBL] [Abstract][Full Text] [Related]